Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Measuring the Amount of Methadone or Morphine in the Blood of Neonates, Infants & Children After Cardiac Surgery.: Complete Statistical AnalysisIndependent statistical analysis of Measuring the Amount of Methadone or Morphine in the Blood of Neonates, Infants & Children After Cardiac Surgery.: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- Measuring the Preferences of Patients With Type II Diabetes Using Best-worst Scaling and Discrete Choice Experiment: Complete Statistical AnalysisIndependent statistical analysis of Measuring the Preferences of Patients With Type II Diabetes Using Best-worst Scaling and Discrete Choice Experiment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Meat Protein and Calcium: Do They Interact Synergistically or Antagonistically?: Complete Statistical AnalysisIndependent statistical analysis of Meat Protein and Calcium: Do They Interact Synergistically or Antagonistically?: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00700804).
- Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence: Complete Statistical AnalysisIndependent statistical analysis of Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Mechanical Intervention on the Scalp Microbiome: Setting the Stage for the Future Management of Cicatricial Alopecias: Complete Statistical AnalysisIndependent statistical analysis of Mechanical Intervention on the Scalp Microbiome: Setting the Stage for the Future Management of Cicatricial Alopecias: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Mechanism of Action of Ocrelizumab in Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of Mechanism of Action of Ocrelizumab in Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03344094).
- Mechanisms and Treatment of Chronic Allograft Injury (CAI) Due to Calcineurin Inhibitor (CNI) Toxicity: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms and Treatment of Chronic Allograft Injury (CAI) Due to Calcineurin Inhibitor (CNI) Toxicity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Mechanisms of Antidepressant Non-Response in Late-Life Depression: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Antidepressant Non-Response in Late-Life Depression: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01931202).
- Mechanisms of Belatacept Effect on Alloimmunity and Antiviral Response After Kidney Transplantation (BMS IM 103-309): Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Belatacept Effect on Alloimmunity and Antiviral Response After Kidney Transplantation (BMS IM 103-309): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Mechanisms of CBD for Chronic Pain: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of CBD for Chronic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04044729).
- Mechanisms of Change, Motivation, and Treatment Outcome in Alcohol Dependence – Posttraumatic Stress Disorder: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Change, Motivation, and Treatment Outcome in Alcohol Dependence - Posttraumatic Stress Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Mechanisms of Chronic Kidney Disease (CKD)-Induced Foam Cell Formation: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Chronic Kidney Disease (CKD)-Induced Foam Cell Formation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01671605).
- Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Hypertension in Women With Polycystic Ovary Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04327934).
- Mechanisms of Hypoglycemia Associated Autonomic Failure: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Hypoglycemia Associated Autonomic Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00678145).
- Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ART: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ART: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Mechanisms of Lipodystrophy in HIV-Infected Pateints: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Lipodystrophy in HIV-Infected Pateints: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00457665).
- Mechanisms of Non-Invasive Neuromodulation Interventions: Influence on Human Neurochemistry and Functional Connectivity: Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Non-Invasive Neuromodulation Interventions: Influence on Human Neurochemistry and Functional Connectivity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Mechanisms of Refractory Hypertension (Reserpine): Complete Statistical AnalysisIndependent statistical analysis of Mechanisms of Refractory Hypertension (Reserpine): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03223272).
- Mechanistic Drivers of Acute PAPE Responsiveness: Muscle Architecture, Contractile Kinetics, and Excitability in a Randomized Controlled Trial: Complete Statistical AnalysisIndependent statistical analysis of Mechanistic Drivers of Acute PAPE Responsiveness: Muscle Architecture, Contractile Kinetics, and Excitability in a Randomized Controlled Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- MeCISIndependent statistical analysis of MethaCholine Bronchoprovocation Study (MeCIS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00705341).
- MED-COMMIndependent statistical analysis of Minimizing Harm From ADEs by Improving Nurse-Physician Communication: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00574990).
- MEDALISTIndependent statistical analysis of A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- MEDARDIndependent statistical analysis of Lanreotide Autogel in the Symptomatic Treatment of Refractory Diarrhea: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00891371).
- MEDEXIndependent statistical analysis of A Multi-level Life-span Characterization of Adult-depression and Effects of Medication and Exercise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MEDEXIndependent statistical analysis of Mindfulness-Based Stress Reduction, Health Education and Exercise: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02665481).
- MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast Cancer: Complete Statistical AnalysisIndependent statistical analysis of MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.: Complete Statistical AnalysisIndependent statistical analysis of MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03611556).
- MediBeat – HeartBeat Observation Trial: Complete Statistical AnalysisIndependent statistical analysis of MediBeat - HeartBeat Observation Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04082819).
- MEDIC-1Independent statistical analysis of Pharmacist-led Group Medical Visits to Help With Diabetes Management: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00554671).
- MEDIC-HFIndependent statistical analysis of Group Medical Visits in Heart Failure: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02481921).
- Medical Treatment of “High-Risk” Neurofibromas: Complete Statistical AnalysisIndependent statistical analysis of Medical Treatment of "High-Risk" Neurofibromas: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00846430).
- Medication Development for Protracted Abstinence in Alcoholism: CORT118335 Versus Placebo: Complete Statistical AnalysisIndependent statistical analysis of Medication Development for Protracted Abstinence in Alcoholism: CORT118335 Versus Placebo: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04466215).
- Medication Development in Alcoholism: Suvorexant Versus Placebo: Complete Statistical AnalysisIndependent statistical analysis of Medication Development in Alcoholism: Suvorexant Versus Placebo: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04229095).
- Medication Treatment for Depression in Nursing Home Residents: Complete Statistical AnalysisIndependent statistical analysis of Medication Treatment for Depression in Nursing Home Residents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00076622).
- Medications for Stopping Cocaine Dependence and Preventing Relapse: Complete Statistical AnalysisIndependent statistical analysis of Medications for Stopping Cocaine Dependence and Preventing Relapse: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00218023).
- MediGuide Registry: Complete Statistical AnalysisIndependent statistical analysis of MediGuide Registry: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02470312).
- Meditation-CBT for Opioid-treated Chronic Low Back Pain: Complete Statistical AnalysisIndependent statistical analysis of Meditation-CBT for Opioid-treated Chronic Low Back Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01775995).
- MEDITOXIN® Versus BOTOX® in the Treatment of Post-stroke Spasticity of the Upper Limb Spasticity: Complete Statistical AnalysisIndependent statistical analysis of MEDITOXIN® Versus BOTOX® in the Treatment of Post-stroke Spasticity of the Upper Limb Spasticity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- MedOPTIndependent statistical analysis of Medication Optimization Using Pharmacogenetic Testing and the G-DIG to Reduce Polypharmacy in a Mental Health Population: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- MeDSIndependent statistical analysis of A Mixed Methods Approach to the Development and Testing of the Measure of Drug Self-Management (MeDS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- MedstarBC2Independent statistical analysis of MedStar Diabetes Pathway Chart Reviews: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03442595).
- Medtronic MiniMed Implantable Insulin Pump: Complete Statistical AnalysisIndependent statistical analysis of Medtronic MiniMed Implantable Insulin Pump: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00298740).
- Medtronic Resolute Onyx 2.0 mm Clinical Study: Complete Statistical AnalysisIndependent statistical analysis of Medtronic Resolute Onyx 2.0 mm Clinical Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02412501).
- Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study: Complete Statistical AnalysisIndependent statistical analysis of Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03635424).
- Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy: Complete Statistical AnalysisIndependent statistical analysis of Megestrol Acetate in Treating Weight Loss or Anorexia in Young Patients With Malignancies Who Are Undergoing Radiation Therapy and/or Chemotherapy: primary endpoint results, effect estimate with confidence interval,…
- Meibomian Gland Dysfunction Treatment: Complete Statistical AnalysisIndependent statistical analysis of Meibomian Gland Dysfunction Treatment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04229888).
- MEK InhibitorIndependent statistical analysis of MEK Inhibitor PD-0325901 Trial in Adolescents and Adults With NF1: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02096471).
- MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma: Complete Statistical AnalysisIndependent statistical analysis of MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC): Complete Statistical AnalysisIndependent statistical analysis of MEK Inhibitor MSC1936369B Plus FOLFIRI in Second Line K-Ras Mutated Metastatic Colorectal Cancer (mCRC): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- MEK162Independent statistical analysis of A Phase I/Ib Study of MEK162, a MEK Inhibitor, in Combination With Carboplatin and Pemetrexed in Patients With Non-squamous Carcinoma of the Lung: primary endpoint results, effect estimate…